Share
963 Posts.
lightbulb Created with Sketch. 170
clock Created with Sketch. 27/04/25
23:46
Share
Originally posted by Cuprum29:
↑
Much as I like my investments to succeed, I have mixed feelings about this.
Expand
At least they should not be concerned with submitting a pediatric plan for any phase 3 or AA protocols.
Originally posted by Tradeyoursoul:
↑
Some of those may have doubled up but im sure everyone can work it out. The EOP reads as it is, end of phase meeting Q4 which i think it will be the fda telling Alterity what path they can or need to walk next once they have collaberated the full phase 2 results (201-202) which can only be done after phase 2 202 topline data is released mid year . It also states that companies will have multiple meetings with fda in between. Everything seems to be cruising along as it should be without corners being cut as far as I can tell.
Expand
(20min delay)